Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 7
198
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Two new triterpenoid glycosides from Bacopa monnieri and their cytotoxic activity

, , , , , , , , & show all
Pages 1120-1126 | Received 22 May 2022, Accepted 29 Sep 2022, Published online: 14 Oct 2022
 

Abstract

Using combined chromatographic methods, two new triterpenoid glycosides, bacopasaponin K (1) and bacopasaponin L (2), along with eight known compounds, bacopaside IV (3), bacopaside VII (4), bacopasaponin E (5), bacoside A3 (6), bacopasaponin F (7), bacopasaponin C (8), bacopaside I (9), and bacopaside II (10) were isolated from the methanol extract of the Bacopa monnieri. Their structures were elucidated by 1D-, 2D-NMR spectroscopic analysis, HR-ESI-MS and comparing with the NMR data reported in the literature. All these compounds were evaluated for their cytotoxic activity using the cell counting kit-8 (CCK-8) assay. Compounds 4, 6, 8, and 10 exhibited potential cytotoxic effects against human lung cancer cells (PC9) and human colon cancer cells (SW620).

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Vietnam Academy of Science and Technology (Grant no. NVCC38.06/22-23); the Ministry of Education, Science and Technology, Republic of Korea (Grant no. NRF-2021K2A9A1A06086013 and 2022R1F1A1063364).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.